MEGAN CROWLEY: Open Payments
NPI 1972086452 · BELLVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 40 payments from 13 companies in 2025. Trend: 2023 $655 · 2024 $323 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $222 |
| AstraZeneca Pharmaceuticals LP | 9 | $148 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: AIRSUPRA, UBRELVY, QULIPTA, VRAYLAR, SPRAVATO, Symbravo, REXULTI, BREZTRI.
Industry payments across OH — which companies pay providers there.
